|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 17724 |
FusionGeneSummary for IRF2_ENPP6 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: IRF2_ENPP6 | Fusion gene ID: 17724 | Hgene | Tgene | Gene symbol | IRF2 | ENPP6 | Gene ID | 3660 | 133121 |
| Gene name | interferon regulatory factor 2 | ectonucleotide pyrophosphatase/phosphodiesterase 6 | |
| Synonyms | IRF-2 | NPP6 | |
| Cytomap | 4q35.1 | 4q35.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | interferon regulatory factor 2 | ectonucleotide pyrophosphatase/phosphodiesterase family member 6B830047L21RikE-NPP 6GPC-CpdeNPP-6choline-specific glycerophosphodiester phosphodiesteraseglycerophosphocholine cholinephosphodiesterase | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | P14316 | Q6UWR7 | |
| Ensembl transtripts involved in fusion gene | ENST00000393593, ENST00000512020, | ENST00000296741, | |
| Fusion gene scores | * DoF score | 3 X 2 X 5=30 | 2 X 3 X 3=18 |
| # samples | 5 | 4 | |
| ** MAII score | log2(5/30*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/18*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: IRF2 [Title/Abstract] AND ENPP6 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | IRF2 | GO:0051607 | defense response to virus | 21478870 |
| Tgene | ENPP6 | GO:0006629 | lipid metabolic process | 15788404 |
| Tgene | ENPP6 | GO:0019695 | choline metabolic process | 15788404 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LIHC | TCGA-BW-A5NP-01A | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185033962 | - |
| TCGA | LD | PRAD | TCGA-CH-5764-01A | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185045425 | - |
| TCGA | LD | SKCM | TCGA-GF-A769-01A | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185074886 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000393593 | ENST00000296741 | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185033962 | - |
| 5UTR-3CDS | ENST00000512020 | ENST00000296741 | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185033962 | - |
| 5UTR-3CDS | ENST00000393593 | ENST00000296741 | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185045425 | - |
| 5UTR-3CDS | ENST00000512020 | ENST00000296741 | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185045425 | - |
| 5UTR-3CDS | ENST00000393593 | ENST00000296741 | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185074886 | - |
| 5UTR-3CDS | ENST00000512020 | ENST00000296741 | IRF2 | chr4 | 185395533 | - | ENPP6 | chr4 | 185074886 | - |
Top |
FusionProtFeatures for IRF2_ENPP6 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| IRF2 | ENPP6 |
| Specifically binds to the upstream regulatory region oftype I IFN and IFN-inducible MHC class I genes (the interferonconsensus sequence (ICS)) and represses those genes. Also acts asan activator for several genes including H4 and IL7.Constitutively binds to the ISRE promoter to activate IL7.Involved in cell cycle regulation through binding the site II(HiNF-M) promoter region of H4 and activating transcription duringcell growth. Antagonizes IRF1 transcriptional activation.{ECO:0000269|PubMed:12738767, ECO:0000269|PubMed:15226432,ECO:0000269|PubMed:18514056, ECO:0000269|PubMed:9540062}. | Choline-specific glycerophosphodiesterphosphodiesterase. The preferred substrate may belysosphingomyelin (By similarity). Hydrolyzeslysophosphatidylcholine (LPC) to form monoacylglycerol andphosphorylcholine but not lysophosphatidic acid, showing it has alysophospholipase C activity. Has a preference for LPC with short(12:0 and 14:0) or polyunsaturated (18:2 and 20:4) fatty acids.Also hydrolyzes glycerophosphorylcholine andsphingosylphosphorylcholine efficiently. Hydrolyzes the classicalsubstrate for phospholipase C, p-nitrophenyl phosphorylcholine invitro, while it does not hydrolyze the classical nucleotidephosphodiesterase substrate, p-nitrophenyl thymidine 5'-monophosphate. Does not hydrolyze diacyl phospholipids such asphosphatidylethanolamine, phosphatidylinositol,phosphatidylserine, phosphatidylglycerol and phosphatidic acid.{ECO:0000250, ECO:0000269|PubMed:15788404}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for IRF2_ENPP6 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for IRF2_ENPP6 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| IRF2 | CSNK2A1, PRKACA, KAT2B, EP300, KAT2A, BRD7, NFKB1, RELA, IRF8, ATG7, IRF2BPL, FOXK1, FOXK2, HCFC1, HCFC2, IRF2BP1, IRF2BP2, AP5Z1, PPP3CA, PPP3CB, MDM2, APP, HSP90AA1, FKBP7, PRDM1, IRF1, NCL, FAM208B, CTSS | ENPP6 | CTPS2, OCRL, MEX3B, DIAPH3, SACS, NDUFA7, SCAMP1, PIGS, EMC3, NDUFB9, STX7, NUP85, ZBTB33, IMPAD1, PTPN1, RUNDC1, STEAP3, GLB1L2, CRLF3, NDUFB3, TMTC3, GNPAT, LMF1, VAMP3, RIPK4, SLC26A6, GLMN, NDUFB8, EMC7, ND5, LMF2, C14orf80, TMEM206, NDUFB4, NDUFB5, ALG9, EMC8, MKS1, USP22, AGTRAP |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for IRF2_ENPP6 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for IRF2_ENPP6 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | IRF2 | C2239176 | Liver carcinoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|